Robust kinetic model for quantification of P-glycoprotein (P-gp) function under altered metabolism and after P-gp inhibition using (R)[C-11]verapamil and PET

被引：0

作者：

Wang, Shaonan ^{[1
]}

Feldmann, Maria ^{[2
]}

Hinz, Rainer ^{[1
]}

McMahon, Adam ^{[1
]}

Koepp, Matthias ^{[2
]}

Jackson, Alan ^{[1
]}

Asselin, Marie-Claude ^{[1
]}

机构：

[1] Univ Manchester, Sch Canc & Enabling Sci, Wolfson Mol Imaging Ctr, Manchester M13 9PL, Lancs, England

[2] UCL, Inst Neurol, London WC1E 6BT, England

来源：

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2012年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S169 / S170

页数：2

共 50 条

[1] IS INHIBITION OF P-GLYCOPROTEIN (P-GP) SUBSTRATE DEPENDENT?
Louie, Steven W.
Hsiao, Peng
Unadkat, Jashvant D.
DRUG METABOLISM REVIEWS, 2014, 45 : 252 - 253
[2] Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
Dewanjee, Saikat
Dua, Tarun K.
Bhattacharjee, Niloy
Das, Anup
Gangopadhyay, Moumita
Khanra, Ritu
Joardar, Swarnalata
Riaz, Muhammad
De Feo, Vincenzo
Zia-Ul-Haq, Muhammad
MOLECULES, 2017, 22 (06)
[3] Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET
Martin Bauer
Rudolf Karch
Friederike Neumann
Aiman Abrahim
Claudia C. Wagner
Kurt Kletter
Markus Müller
Markus Zeitlinger
Oliver Langer
European Journal of Clinical Pharmacology, 2009, 65 : 941 - 946
[4] Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET
Bauer, Martin
Karch, Rudolf
Neumann, Friederike
Abrahim, Aiman
Wagner, Claudia C.
Kletter, Kurt
Mueller, Markus
Zeitlinger, Markus
Langer, Oliver
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (09) : 941 - 946
[5] Mapping regional P-gp function in normal and epileptic rat brain with (R)-[11C] verapamil PET
Langer, Oliver
Kuntner, Claudia
Bankstahl, Jens
Bankstahl, Marion
Wanek, Thomas
Stanek, Johann
Mueller, Markus
Loescher, Wolfgang
JOURNAL OF NUCLEAR MEDICINE, 2009, 50
[6] Open field behavior of rats after neuroleptic treatment with and without inhibition of P-glycoprotein (P-gp)
Schmitt, U
Härtter, S
Hiemke, C
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R5 - R5
[7] In vivo P-glycoprotein (P-gp) transport activity in the pregnant macaque (M. nemestrina) as measured by biodistribution of 11C-verapamil and PET.
Link, JM
Unadkat, JD
Muzi, M
Dupuis, A
Mankoff, DA
Shoner, SC
JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 277P - 277P
[8] Effects of atazanavir on P-glycoprotein (P-gp) transport and CYP3A metabolism in vitro
Perloff, ES
Duan, SX
Greenblatt, DJ
von Moltke, LL
FASEB JOURNAL, 2005, 19 (04): : A544 - A544
[9] KINETIC MODEL-BASED DEFINITION FOR CALCULATING P-GP EFFLUX ACTIVITY TO REDUCE THE VARIABILITY OF IN VITRO P-GP INHIBITION POTENCY
Kishimoto, Wataru
Ishiguro, Naoki
Ludwig-Schwellinger, Eva
Ebner, Thomas
Maeda, Kazuya
Yamamura, Norio
Sugiyama, Yuichi
DRUG METABOLISM REVIEWS, 2015, 47 : 264 - 264
[10] Evaluation of tracer kinetic models for quantification of P-glycoprotein function using (R)-[11C]verapamil and PET
Lubberink, Mark
Luurtsema, Gert
van Berckel, Bart N. M.
Boellaard, Ronald
Toornvliet, Rolf
Windhorst, Albert D.
Franssen, Eric J. F.
Lammertsma, Adriaan A.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (02): : 424 - 433

← 1 2 3 4 5 →